InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF)
Boehringer Ingelheim and Duke Clinical Research Institute Form Collaborative Partnership to Study the Natural History of Idiopathic Pulmonary Fibrosis (IPF)
The ATS Foundation, Coalition for Pulmonary Fibrosis, and the Pulmonary Fibrosis Foundation Award $100,000 to Chi Hung, MD to Study Idiopathic Pulmonary Fibrosis.
The Pulmonary Fibrosis Community Again Commends the Pulmonary Fibrosis Foundation's Biennial PFF Summit
TNF-α Accelerates the Resolution of Established Pulmonary Fibrosis in Mice by Targeting Pro-Fibrotic Lung Macrophages
Pulmonary Fibrosis Foundation Announces Plans to Establish a Care Center Network and Patient Registry
Pulmonary Fibrosis Foundation Raises Funds and Awareness While Recognizing Outstanding Leaders in the Pulmonary Fibrosis Community
POSTED BY PULMONARY FIBROSIS FOUNDATION ON 11/8/2013